Citations

Mayo Clinic

Showing 10 of 108551 citations.

The Genetic Counselor's Role in Managing Ethical Dilemmas Arising in the Laboratory Setting
Balcom, Jessica R. , Kotzer, Katrina E. , Waltman, Lindsey, Kemppainen, Jennifer L., Thomas, Brittany C. , Waltman, Lindsey A

Journal of Genetic Counseling | April 21, 2016 | Volume: 25 | Issue: 5 | Pages: 838-854

10.1007/s10897-016-9957-6 | PMID 27103422 Get It

AbstractEthical dilemmas are encountered commonly in the setting of the clinical genetic testing laboratory due to the complexity of genetic testing and the number of relevant stakeholders involved in the genetic testing process. Based on their clinical training and role within the laboratory, genetic counselors are uniquely equipped to identify and facilitate management of ethical dilemmas. This paper reviews the historical context of ethical theory and its application to the field of genetic counseling. Theoretical and applied ethics are explored in the context of dilemmas arising in the laboratory setting, with a focus on the role of the laboratory genetic counselor in managing ethical dilemmas. Two illustrative case examples are provided.
Accurate Measurement of Postprandial Glucose Turnover: Why Is It Difficult and How Can It Be Done (Relatively) Simply?
Rizza, Robert A., Toffolo, Gianna , Cobelli, Claudio

Diabetes | April 21, 2016 | Volume: 65 | Issue: 5 | Pages: 1133-1145

10.2337/db15-1166 | PMID 27208180 Get It

Fasting hyperglycemia occurs when an excessive rate of endogenous glucose production (EGP) is not accompanied by an adequate compensatory increase in the rate of glucose disappearance (Rd). The situation following food ingestion is more complex as the amount of glucose that reaches the circulation for disposal is a function of the systemic rate of appearance of the ingested glucose (referred to as the rate of meal appearance [Rameal]), the pattern and degree of suppression of EGP, and the rapidity of stimulation of the Rd. In an effort to measure these processes, Steele et al. proposed what has come to be referred to as the dual-tracer method in which the ingested glucose is labeled with one tracer while a second tracer is infused intravenously at a constant rate. Unfortunately, subsequent studies have shown that although this approach is technically simple, the marked changes in plasma specific activity or the tracer-to-tracee ratio, if stable tracers are used, introduce a substantial error in the calculation of Rameal, EGP, and Rd, thereby leading to incorrect and at times misleading results. This Perspective discusses the causes of these so-called “nonsteady-state” errors and how they can be avoided by the use of the triple-tracer approach.
Whole blood for hemostatic resuscitation of major bleeding
Spinella, Philip C. , Pidcoke, Heather F. , Hervig, Tor , Fisher, Andrew D , Jenkins, Donald H. , Yazer, Mark H. , Stubbs, James R. , Murdock, Alan D., Sailliol, A., Ness, Paul M., Cap, Andrew P., Stubbs, James, Strandenes, Geir , Cap, Andrew P., Spinella, Philip C

Transfusion | April 21, 2016 | Volume: 56 | Issue: S2 | Pages: No page available

10.1111/trf.13491 | PMID 27100756 Get It

Recent combat experience reignited interest in transfusing whole blood (WB) for patients with life‐threatening bleeding. US Army data indicate that WB transfusion is associated with improved or comparable survival compared to resuscitation with blood components. These data complement randomized controlled trials that indicate that platelet (PLT)‐containing blood products stored at 4°C have superior hemostatic function, based on reduced bleeding and improved functional measures of hemostasis, compared to PLT‐containing blood products at 22°C. WB is rarely available in civilian hospitals and as a result is rarely transfused for patients with hemorrhagic shock. Recent developments suggest that impediments to WB availability can be overcome, specifically the misconceptions that WB must be ABO specific, that WB cannot be leukoreduced and maintain PLTs, and finally that cold storage causes loss of PLT function. Data indicate that the use of low anti‐A and anti‐B titer group O WB is safe as a universal donor, WB can be leukoreduced with PLT‐sparing filters, and WB stored at 4°C retains PLT function during 15 days of storage. The understanding that these perceived barriers are not insurmountable will improve the availability of WB and facilitate its use. In addition, there are logistic and economic advantages of WB‐based resuscitation compared to component therapy for hemorrhagic shock. The use of low‐titer group O WB stored for up to 15 days at 4°C merits further study to compare its efficacy and safety with current resuscitation approaches for all patients with life‐threatening bleeding.
Insulin/glucose induces natriuretic peptide clearance receptor in human adipocytes: a metabolic link with the cardiac natriuretic pathway
Bordicchia, Marica, Ceresiani, Monica, Pavani, M., Polito, M., Cannone, Valentina , Burnett, John C. , Dessı̀-Fulgheri, Paolo, Sarzani, Riccardo , Minardi, Daniele , Wabitsch, Martin

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | April 21, 2016 | Volume: 311 | Issue: 1 | Pages: R104-R114

10.1152/ajpregu.00499.2015 | PMID 27101299 Get It

Cardiac natriuretic peptides (NP) are involved in cardiorenal regulation and in lipolysis. The NP activity is largely dependent on the ratio between the signaling receptor NPRA and the clearance receptor NPRC. Lipolysis increases when NPRC is reduced by starving or very-low-calorie diet. On the contrary, insulin is an antilipolytic hormone that increases sodium retention, suggesting a possible functional link with NP. We examined the insulin-mediated regulation of NP receptors in differentiated human adipocytes and tested the association of NP receptor expression in visceral adipose tissue (VAT) with metabolic profiles of patients undergoing renal surgery. Differentiated human adipocytes from VAT and Simpson-Golabi-Behmel Syndrome (SGBS) adipocyte cell line were treated with insulin in the presence of high-glucose or low-glucose media to study NP receptors and insulin/glucose-regulated pathways. Fasting blood samples and VAT samples were taken from patients on the day of renal surgery. We observed a potent insulin-mediated and glucose-dependent upregulation of NPRC, through the phosphatidylinositol 3-kinase pathway, associated with lower lipolysis in differentiated adipocytes. No effect was observed on NPRA. Low-glucose medium, used to simulate in vivo starving conditions, hampered the insulin effect on NPRC through modulation of insulin/glucose-regulated pathways, allowing atrial natriuretic peptide to induce lipolysis and thermogenic genes. An expression ratio in favor of NPRC in adipose tissue was associated with higher fasting insulinemia, HOMA-IR, and atherogenic lipid levels. Insulin/glucose-dependent NPRC induction in adipocytes might be a key factor linking hyperinsulinemia, metabolic syndrome, and higher blood pressure by reducing NP effects on adipocytes.
Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study
Jayasekara, Harindra , Reece, Jeanette C. , Buchanan, Daniel D. , Rosty, Christophe , Dashti, S. Ghazaleh , Ouakrim, Driss Ait , Winship, Ingrid , Boussioutas, Alex , Giles, Graham G. , Ahnen, Dennis J. , Lowery, Jan T. , Haile, Robert W. , Gallinger, Steven, Lindor, Noralane M. , Parry, Susan, Jenkins, Mark A. , Win, Aung Ko , Macrae, Finlay , Casey, Graham , Marchand, Loı̈c Le , Newcomb, Polly A. , Hopper, John L. , Buchanan, Daniel D , Win, Aung K , Giles, Graham G , Jenkins, Mark A , Haile, Robert W , Rosty, Christophe , Winship, Ingrid M , Jayasekara, Harindra

International Journal of Cancer | April 21, 2016 | Volume: 139 | Issue: 5 | Pages: 1081-1090

10.1002/ijc.30153 | PMID 27098183 Get It

Individuals diagnosed with colorectal cancer (CRC) are at risk of developing a metachronous CRC. We examined the associations between personal, tumour‐related and lifestyle risk factors, and risk of metachronous CRC. A total of 7,863 participants with incident colon or rectal cancer who were recruited in the USA, Canada and Australia to the Colon Cancer Family Registry during 1997‐2012, except those identified as high‐risk, for example, Lynch syndrome, were followed up approximately every 5 years. We estimated the risk of metachronous CRC, defined as the first new primary CRC following an interval of at least one year after the initial CRC diagnosis. Observation time started at the age at diagnosis of the initial CRC and ended at the age at diagnosis of the metachronous CRC, last contact or death whichever occurred earliest, or were censored at the age at diagnosis of any metachronous colorectal adenoma. Cox regression was used to derive hazard ratios (HRs) and 95% confidence intervals (CIs). During a mean follow‐up of 6.6 years, 142 (1.81%) metachronous CRCs were diagnosed (mean age at diagnosis 59.8; incidence 2.7/1,000 person‐years). An increased risk of metachronous CRC was associated with the presence of a synchronous CRC (HR = 2.73; 95% CI: 1.30–5.72) and the location of cancer in the proximal colon at initial diagnosis (compared with distal colon or rectum, HR = 4.16; 95% CI: 2.80–6.18). The presence of a synchronous CRC and the location of the initial CRC might be useful for deciding the intensity of surveillance colonoscopy for individuals diagnosed with CRC.
Insights into the pathogenesis of ulcerative colitis from a murine model of stasis-induced dysbiosis, colonic metaplasia, and genetic susceptibility
Ward, Marc A. , Pierre, Joseph F. , Leal, Raquel Franco , Huang, Yong , Shogan, Benjamin D. , Dalal, Sushila , Weber, Christopher R. , Leone, Vanessa , Musch, Mark W. , An, Gary , Rao, Mrinalini C. , Raffals, Laura E. , Antonopoulos, Dionysios A. , Sogin, Mitch, Hyman, Neil , Alverdy, John C. , Chang, Eugene B. , Rubin, David T.

American Journal of Physiology-Gastrointestinal and Liver Physiology | April 21, 2016 | Volume: 310 | Issue: 11 | Pages: G973-G988

10.1152/ajpgi.00017.2016 | PMID 27079612 Get It

Gut dysbiosis, host genetics, and environmental triggers are implicated as causative factors in inflammatory bowel disease (IBD), yet mechanistic insights are lacking. Longitudinal analysis of ulcerative colitis (UC) patients following total colectomy with ileal anal anastomosis (IPAA) where >50% develop pouchitis offers a unique setting to examine cause vs. effect. To recapitulate human IPAA, we employed a mouse model of surgically created blind self-filling (SFL) and self-emptying (SEL) ileal loops using wild-type (WT), IL-10 knockout (KO) (IL-10), TLR4 KO (T4), and IL-10/T4 double KO mice. After 5 wk, loop histology, host gene/protein expression, and bacterial 16s rRNA profiles were examined. SFL exhibit fecal stasis due to directional motility oriented toward the loop end, whereas SEL remain empty. In WT mice, SFL, but not SEL, develop pouchlike microbial communities without accompanying active inflammation. However, in genetically susceptible IL-10-deficient mice, SFL, but not SEL, exhibit severe inflammation and mucosal transcriptomes resembling human pouchitis. The inflammation associated with IL-10 required TLR4, as animals lacking both pathways displayed little disease. Furthermore, germ-free IL-10 mice conventionalized with SFL, but not SEL, microbiota populations develop severe colitis. These data support essential roles of stasis-induced, colon-like microbiota, TLR4-mediated colonic metaplasia, and genetic susceptibility in the development of pouchitis and possibly UC. However, these factors by themselves are not sufficient. Similarities between this model and human UC/pouchitis provide opportunities for gaining insights into the mechanistic basis of IBD and for identification of targets for novel preventative and therapeutic interventions.
A retrospective comparison of programmed intermittent epidural bolus with continuous epidural infusion for maintenance of labor analgesia
Tien, Michael , Allen, Terrence K. , Mauritz, Amy, Habib, Ashraf S.

Current Medical Research and Opinion | April 21, 2016 | Volume: 32 | Issue: 8 | Pages: 1435-1440

10.1080/03007995.2016.1181619 | PMID 27100210 Get It

Chronic sinusitis and dyspnea: Could this be AIDS?
Slavit, David H., Yocum, Michael W., Kern, Eugene B.

Otolaryngology–Head and Neck Surgery | April 21, 2016 | Volume: 103 | Issue: 4 | Pages: 650-652

10.1177/019459989010300422 | PMID 2123327 Get It

The in vivo and in vitro effect of phenylephrine (neo synephrine) on nasal ciliary beat frequency and mucociliary transport
Phillips, P. Perry, McCaffrey, Thomas V., Kern, Eugene B.

Otolaryngology–Head and Neck Surgery | April 21, 2016 | Volume: 103 | Issue: 4 | Pages: 558-565

10.1177/019459989010300406 | PMID 2123313 Get It

Twenty volunteers with normal noses were studied to determine the effect of phenylephrine on nasal ciliary function. In vivo study of this drug was performed in 15 patients and revealed a significant increase in their ciliary beat frequency from a control of 11 Hz to 12.03 Hz (p = 0.001). Mucociliary transit times in these volunteers were also studied, revealing a mean of 9.9 minutes prestimulation and 10.2 minutes poststimulation, which was not statistically significant (p = 0.77). Five additional subjects donated ciliated mucosal samples for in vitro analysis of varying concentrations of this agent that showed a significant ciliostimulatory effect at lower concentrations (0.01%), with a progressive cilioinhibitory effect at higher concentrations (0.25%, 0.5%). The 0.05% concentration showed no significant change in ciliary activity compared to control measurements. These data demonstrate that phenylephrine has a ciliostimulatory effect in vivo, as well as in appropriate concentrations in vitro, and should be safe and relatively nontoxic to the mucociliary apparatus for short‐term use.3
The Otolaryngologic Presentation of Amyotrophic Lateral Sclerosis
Carpenter, Robert J. , McDonald, Thomas J. , Howard, F

Otolaryngology–Head and Neck Surgery | April 21, 2016 | Volume: 86 | Issue: 3 | Pages: No page available

10.1177/019459987808600319 | PMID 112540 Get It

Amyotrophic lateral sclerosis is a progressive degenerative neuromuscular disease of insidious onset. It involves upper and lower motor neurons and causes both spastic and atrophic muscular symptoms. More than one fourth of patients have complaints relating to the head and neck (bulbar palsy); thus, the otolaryngologist may be the first physician to see them. Predominant symptoms are slurred speech, hoarseness, dysphagia, and dyspnea. Muscular weakness, atrophy, and fasciculation are noted on examination. The course is relentless, and only 20% of patients survive five years after diagnosis.